An analysis of ET patients determined this population to have elevated levels of IL-1B, IL-4, IL-6, IL-8, IL-10, IL-12, HGF, GM-CSF, IFN-γ, MCP-1, PDGF-BB, TNF-α, and VEGF. The gene discussed is CXCL8; the disease is essential thrombocythemia.